PY-265
N/A
Report date: 2024/12/12 15:47:52
Base Information
Drug NamePY-265
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesPionyr Immunotherapeutics Inc
China Registration ClassN/A
Develop Information
Active CompaniesFoundery Immune Studio LLCPionyr Immunotherapeutics Inc
Inactive CompaniesN/A
Active Indications
Inactive Indications
Other Information
ATC CodeN/A
Related LinksN/A